The Ethics of Xenotransplantation

Recent scientific advances have made solid organ xenotransplantation (the transplantation of an animal organ into a human being) seem achievable in the next five years. In this seminar (September 25, 2008) Jennifer Girod, J.D., Ph.D., a faculty investigator of the Indiana University Center for Bioethics and an associate with Taft Stettinius & Hollister, LLP, explored the ethical issues involved with this practice, and proposed a model for how to decide who should be included in early clinical trials. She argued that early clinical trials with a genetically engineered pig liver as a bridge-to-transplant makes sense both from the perspective of risks and benefits to third parties, and for the balancing of core values in relation to the individual research participants.

To see the schedule of future Health Care Ethics Seminars, visit the website of the Poynter Center for the Study of Ethics and American Institutions (Indiana University, Bloomington).


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s